Terms: = Ovarian cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984
10 results:
1. hsp90ab1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in ovarian cancer.
Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
[TBL] [Abstract] [Full Text] [Related]
2. ovarian Serous Carcinoma With a Novel hsp90ab1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma.
Lai J; Tong C; Chien JR
Anticancer Res; 2021 Sep; 41(9):4417-4422. PubMed ID: 34475063
[TBL] [Abstract] [Full Text] [Related]
3. Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients.
Fei H; Chen S; Xu C
J Ovarian Res; 2021 Mar; 14(1):41. PubMed ID: 33676525
[TBL] [Abstract] [Full Text] [Related]
4. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in ovarian Tumour Models.
Althurwi SI; Yu JQ; Beale P; Huq F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer.
Lim L; Wu CC; Hsu YT; Sun FJ; Chang CL
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):105-110. PubMed ID: 30638462
[TBL] [Abstract] [Full Text] [Related]
6. Selection of stable expressed reference genes in native and vitrified/thawed human ovarian tissue for analysis by qRT-PCR and Western blot.
Nikishin DA; Filatov MA; Kiseleva MV; Bagaeva TS; Konduktorova VV; Khramova YV; Malinova IV; Komarova EV; Semenova ML
J Assist Reprod Genet; 2018 Oct; 35(10):1851-1860. PubMed ID: 30027530
[TBL] [Abstract] [Full Text] [Related]
7. Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines.
Jacob F; Guertler R; Naim S; Nixdorf S; Fedier A; Hacker NF; Heinzelmann-Schwarz V
PLoS One; 2013; 8(3):e59180. PubMed ID: 23554992
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials.
Mahner S; Eulenburg C; Staehle A; Wegscheider K; Reuss A; Pujade-Lauraine E; Harter P; Ray-Coquard I; Pfisterer J; du Bois A
Eur J Cancer; 2013 Jan; 49(1):142-9. PubMed ID: 22921185
[TBL] [Abstract] [Full Text] [Related]
9. Identification of genes for normalization of quantitative real-time PCR data in ovarian tissues.
Fu J; Bian L; Zhao L; Dong Z; Gao X; Luan H; Sun Y; Song H
Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):568-74. PubMed ID: 20705598
[TBL] [Abstract] [Full Text] [Related]
10. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Wagner TM; Hirtenlehner K; Shen P; Moeslinger R; Muhr D; Fleischmann E; Concin H; Doeller W; Haid A; Lang AH; Mayer P; Petru E; Ropp E; Langbauer G; Kubista E; Scheiner O; Underhill P; Mountain J; Stierer M; Zielinski C; Oefner P
Hum Mol Genet; 1999 Mar; 8(3):413-23. PubMed ID: 9971877
[TBL] [Abstract] [Full Text] [Related]
